DKBIO2019 « DK Bio Access
NMD Pharma ApS « DK Bio Access
Sarcopenia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
NMD Pharma ApS Annual Report for 1 January - 31 December 2017
NMD PHARMA APS innovation strategy - GoodIP
NMD PHARMA APS innovation strategy - GoodIP
NMD Pharma A/S | LinkedIn
Claus Oleson - BioLeader Interview - PIR International
Board of Directors – Initiator Pharma
Denmark News, Reviews & Resources - Labiotech.eu
Patrick Volkert Jozef Johannes Vink har 1 erhvervsrolle » Er bosat i udlandet - ownr®
Nete Huus email address & phone number | NMD Pharma Aps Senior Scientist contact information - RocketReach
NMD Pharma A/S | LinkedIn
NMD Pharma A/S | LinkedIn
NMD Pharma
Synapse - Life Science Connect Aarhus | Aarhus
NMD Pharma Company Profile: Valuation & Investors | PitchBook
NMD Pharma - Crunchbase Company Profile & Funding
NMD Pharma Company Profile | Management and Employees List
NMD pulls in $40M from Jeito-led, Roche-backed syndicate, gaining financial muscle to crack myasthenia gravis market | Fierce Biotech
NMD Pharma
Thomas Groennebaek (@tgroennebaek) / Twitter
ABOUT US | pharma-cosmetics
